Ohio State biotech spinoff targeting MD raises $182M in IPO
November 09, 2021 at 06:33 AM EST
An Ohio State University spinoff developing treatments for "undruggable" diseases has raised $181.5 million in an IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|